This website uses cookies to improve performance and your user experience on our website. If you do not agree with the use of cookies other than the essential ones, you can manage your preferences by clicking on "Cookie Settings"
Ricardo J. Alves Silva, Partner at BMA, will be attending the Medicines for Europe 32nd Annual Conference, taking place in Athens on 10–11 June 2026, representing EQUALMED - Associação Portuguesa de Medicamentos pela Equidade em Saúde.
This year’s conference, held under the theme “The Off-Patent Medicines Industry: A Strategic Partner for Europe”, will bring together industry leaders, policymakers and healthcare stakeholders to discuss key issues for the sector, including Europe’s strategic autonomy, equitable access to medicines, competitiveness, and the impact of upcoming environmental regulations.
We look forward to contributing to these important discussions in Athens.
Ricardo J. Alves Silva, Partner at BMA, will be attending the Medicines for Europe 32nd Annual Conference, taking place in Athens on 10–11 June 2026, representing EQUALMED - Associação Portuguesa de Medicamentos pela Equidade em Saúde.
This year’s conference, held under the theme “The Off-Patent Medicines Industry: A Strategic Partner for Europe”, will bring together industry leaders, policymakers and healthcare stakeholders to discuss key issues for the sector, including Europe’s strategic autonomy, equitable access to medicines, competitiveness, and the impact of upcoming environmental regulations.
We look forward to contributing to these important discussions in Athens.